Thermo Fisher Scientific Inc. (NYSE: TMO) today announced its second quarter financial results for the period ended June 27, 2020.
Net income for the second quarter was $1.15 billion, or $2.90 per share, compared to net income of $1.12 billion, or $2.77 per share in the second quarter of 2019
Revenues up 10% to $6.97 billion.
Our teams worked with relentless intensity to establish Thermo Fisher as a global leader in COVID-19 testing and leverage our pharma services leadership to support the development and production of therapeutics and vaccines. At the same time, we continued to execute our growth strategy, developing new products and capabilities across our businesses that will position us well for years to come.– Marc N. Casper, CEO
Earlier we looked into how, during the COVID-19 pandemic, retailers saw changing trends in terms of their assortments and how the acceleration of online shopping led many of them to
Data is at the heart of business innovation. Recognizing this trend, companies are seeking ways to transform their businesses by capturing, analyzing, and mobilizing data. The public cloud is becoming
The second half has been highly rewarding for design software maker Adobe Inc. (NASDAQ: ADBE) amid stable demand for digital content solutions. The company has remained unaffected by the virus-related